Skip to main navigationSkip to main content
The University of Southampton
Southampton Clinical Trials Unit

Active Trials Portfolio

ACCEPT Logo

ACCEPT

A Phase Ib/II combination of acalabrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) for patient Diffuse Large B-cell Lymphoma (DLBCL)

AGILE logo

AGILE

Seamless Phase I/IIa Platform for the Rapid Evaluation of Candidates for COVID-19 treatment.

ARGO logo

ARGO

A phase II Study of Atezolizumab with Rituximab, Gemcitabine and Oxaliplatin in patients with relapsed or refractory Diffuse Large B-Cell Lymphoma who are not candidates for High Dose Therapy

BL13 logo

BL13

A Randomised Phase II Trial Assessing Trimodality Therapy With or Without Adjuvant Durvalumab (MEDI4736) to Treat Patients with Muscle-Invasive Bladder Cancer.  

CONFIRM Logo

CONFIRM

Checkpoint blockade for inhibition of relapsed mesothelioma: A phase III trial to evaluate the efficacy of nivolumab in relapsed mesothelioma

Excalibur logo

EXCALIBUR

EXCALIBUR is a Phase III feasibility trial of SFJD in addition to best current practice for the treatment of AECOPD in UK primary care.  

FORECAST Logo

FORECAST

Fractional Flow Reserve Derived from Computed Tomography Coronary Angiography in the Assessment and Management of Stable Chest Pain

HARE-40 Logo

HARE-40

Therapeutic HPV vaccine trial +/- anti-CD40 in HPV-driven squamous cell carcinoma

IELSG 32 Logo

IELSG 32

A randomised Phase II Trial on high-dose Methotrexate and Cytarabine, with or without Thiotepa and Rituximab followed by brain irradiation vs. high-dose chemotherapy patients with primary CNS lymphoma

IELSG 37 Logo

IELSG 37

A randomized, open-label, two-arm phase III comparative study assessing the role of mediastinal radiotherapy after Rituximab chemotherapy to patients with newly diagnosed Primary Mediastinal Large B-Cell Lymphoma

IELSG42 Logo

IELSG 42

A phase II trial assessing sequential Methotrexate-Aracytin-based and R-ICE combinations, followed by high-dose chemotherapy in patients with systemic B-cell lymphoma with central nervous system involvement

MAPLE Logo

MaPLe

Molecular Profiling for Lymphoma

Neo-AEGIS Logo

Neo-AEGIS

Neoadjuvant and adjuvant chemotherapy (Investigator’s choice Modified MAGIC or FLOT regimen) vs. neoadjuvant chemoradiation (CROSS protocol) in adenocarcinoma of the oesophagus and oesophago-gastric junction

OCTOPuS Logo

OCTOPuS

Optimising Cardiac Surgery ouTcOmes in People with diabeteS – Intervention Development Study

ORANGE II logo

Orange II Plus

An international multicentre randomised controlled trial comparing open and laparoscopic hemihepatectomy within an enhanced recovery (ERAS) programme

ProCAID Logo

ProCAID

An open label phase I/randomised, double blind phase II study in metastatic castration resistant Prostate Cancer of AZD5363 In combination with Docetaxel and prednisolone chemotherapy

REMoDL-B Logo

REMoDL-B

A Randomised Evaluation of Molecular guided therapy for Diffuse Large B-cell Lymphoma with Bortezomib

RIVA Logo

RiVa

A phase IIa study of Rituximab and Varlilumab in relapsed or refractory B-cell malignancies

SAFA Logo

SAFA

A pragmatic multicentre double-blind randomised superiority trial investigating the clinical and cost-effectiveness of spironolactone for moderate or severe persistent adult female acne

SPIRE Logo

SPIRE

A phase Ib/randomised IIa open label clinical trial combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer.

SupportBack2 logo

SupportBack2

Supporting self-management of low back pain with an internet intervention in primary care: A randomised controlled trial of clinical and cost-effectiveness.

Privacy Settings